Lululemon tumbles as tariff uncertainty, weak demand hit forecasts
By Ananya Mariam Rajesh (Reuters) -Lululemon Athletica’s shares fell 13% on Friday after the sportswear maker gave downbeat annual forecasts…
Measles outbreak worsens as Texas, New Mexico cases rise 20% in 3 days
(Reuters) – Texas and New Mexico health departments said on Friday that the number of measles cases in their states…
US FDA approves Sanofi’s bleeding disorder therapy
By Sriparna Roy and Padmanabhan Ananthan (Reuters) -The U.S. Food and Drug Administration approved French drugmaker Sanofi’s hemophilia therapy, introducing…
Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
By Jonathan Stempel (Reuters) – A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S.…
Musk to visit CIA on Monday, spokesperson says
WASHINGTON (Reuters) -Billionaire Elon Musk, who serves as a top adviser to President Donald Trump, will visit the Central Intelligence…
OpenAI must complete for-profit transition by year-end to raise full $40 billion
By Krystal Hu and Jaspreet Singh (Reuters) – OpenAI must transition to a for-profit company by the end of the…
Top vaccine official Peter Marks forced out at FDA, WSJ reports
(Reuters) -The U.S. Food and Drug Administration’s top vaccine official, Peter Marks, has been pushed out, the Wall Street Journal…
No sign Trump will honor US auto tariff protections won by Canada, Mexico in 2018
By David Lawder and David Shepardson (Reuters) – Canada and Mexico won protections against potential new U.S. auto tariffs in…
IMF assessing Trump tariff plans but does not see US recession
WASHINGTON (Reuters) -The International Monetary Fund is continuing to assess the impact of President Donald Trump’s tariff plans, including his…
H&M reports sluggish start to spring sales
By Helen Reid LONDON (Reuters) -H&M’s sales were up just 1% in March after a weaker than expected first quarter,…